{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:17Z","timestamp":1787021357677,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01-CA29605"],"award-info":[{"award-number":["P01-CA29605"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA189163"],"award-info":[{"award-number":["R01 CA189163"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA093372"],"award-info":[{"award-number":["P50-CA093372"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA016520"],"award-info":[{"award-number":["P30-CA016520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1245\/s10434-016-5646-9","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T10:20:50Z","timestamp":1478082050000},"page":"952-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis"],"prefix":"10.1245","volume":"24","author":[{"given":"Giorgos","family":"Karakousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis A.","family":"Gimotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Shin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalyn G.","family":"Neuwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Fraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Czerniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Faries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"issue":"793\u20136","key":"5646_CR1","first-page":"2","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793\u20136.","journal-title":"WHO Melanoma Programme. Lancet."},{"key":"5646_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","volume":"7","author":"CM Balch","year":"2000","unstructured":"Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u00a0mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7:87\u201397.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR3","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2004.12.015","volume":"22","author":"PA Gimotty","year":"2004","unstructured":"Gimotty PA, Guerry D, Ming ME, Elenitsas R, Xu X, Czerniecki B, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22:3668\u201376.","journal-title":"J Clin Oncol."},{"key":"5646_CR4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol."},{"key":"5646_CR5","unstructured":"Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, et al. SEER Cancer Statistics Review, 1975\u20132009 (Vintage 2009 Populations) National Cancer Institute, Bethesda, MD, 2011. http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/ ."},{"key":"5646_CR6","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","volume":"30","author":"SL Wong","year":"2012","unstructured":"Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30:2912\u20138.","journal-title":"J Clin Oncol."},{"key":"5646_CR7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.6004\/jnccn.2012.0038","volume":"10","author":"G Plitas","year":"2012","unstructured":"Plitas G, Ariyan CE. Controversies in the management of regional nodes in melanoma. J Natl Compr Cancer Netw. 2012;10:414\u201321.","journal-title":"J Natl Comprehensive Cancer Network."},{"key":"5646_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.cco.0000208793.30065.77","volume":"18","author":"JH Ra","year":"2006","unstructured":"Ra JH, McMasters KM, Spitz FR. Should all melanoma patients undergo sentinel lymph node biopsy? Curr Opin Oncol. 2006;18:185\u20138.","journal-title":"Curr Opin Oncol."},{"key":"5646_CR9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","volume":"13","author":"GC Karakousis","year":"2006","unstructured":"Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, et al. Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol. 2006;13:533\u201341.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archsurg.2009.271","volume":"145","author":"MB Faries","year":"2010","unstructured":"Faries MB, Wanek LA, Elashoff D, Wright BE, Morton DL. Predictors of occult nodal metastasis in patients with thin melanoma. Arch Surg. 2010;145:137\u201342.","journal-title":"Arch Surg."},{"key":"5646_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cncr.24044","volume":"115","author":"MA Warycha","year":"2009","unstructured":"Warycha MA, Zakrzewski J, Ni Q, Shapiro RL, Berman RS, Pavlick AC, Polsky D, et al. Meta-analysis of sentinel lymph node positivity in thin melanoma (\u22641\u00a0mm). Cancer. 2009;115:869\u201379.","journal-title":"Cancer."},{"key":"5646_CR12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1245\/s10434-006-9319-y","volume":"14","author":"GC Karakousis","year":"2007","unstructured":"Karakousis GC, Gimotty PA, Czerniecki BJ, Elder DE, Elenitsas R, Ming ME, et al. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN staging biopsy in these patients. Ann Surg Oncol. 2007;14:1596\u2013603.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR13","doi-asserted-by":"crossref","unstructured":"Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R Morton DL. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008;143:892\u20139; discussion 9\u2013900.","DOI":"10.1001\/archsurg.143.9.892"},{"key":"5646_CR14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","volume":"13","author":"JM Ranieri","year":"2006","unstructured":"Ranieri JM, Wagner JD, Wenck S, Johnson CS Coleman JJ III. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol. 2006;13:927\u201332.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1245\/s10434-013-3313-y","volume":"21","author":"EK Bartlett","year":"2014","unstructured":"Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, et al. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy. Ann Surg Oncol. 2014;21:643\u20139.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR16","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","volume":"31","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013;31:4387\u201393.","journal-title":"J Clin Oncol."},{"key":"5646_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/SLA.0b013e3182306c72","volume":"255","author":"R Murali","year":"2012","unstructured":"Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, et al. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Ann Surg. 2012;255:128\u201333.","journal-title":"Ann Surg."},{"key":"5646_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1245\/ASO.2006.02.021","volume":"13","author":"SL Wong","year":"2006","unstructured":"Wong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol. 2006;13:302\u20139.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR19","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1002\/cncr.24660","volume":"115","author":"C Gajdos","year":"2009","unstructured":"Gajdos C, Griffith KA, Wong SL, Johnson TM, Chang AE, Cimmino VM, et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer. 2009;115:5752\u201360.","journal-title":"Cancer."},{"key":"5646_CR20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10434-000-0160-4","volume":"7","author":"JE Gershenwald","year":"2000","unstructured":"Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (\u22654\u00a0mm) primary melanoma. Ann Surg Oncol. 2000;7:160\u20135.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF02574492","volume":"9","author":"JF Thompson","year":"2002","unstructured":"Thompson JF Shaw HM. The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol. 2002;9:719\u201322.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1245\/ASO.2003.03.055","volume":"10","author":"GW Carlson","year":"2003","unstructured":"Carlson GW, Murray DR, Hestley A, Staley CA, Lyles RH Cohen C. Sentinel lymph node mapping for thick (\u22654\u00a0mm) melanoma: should we be doing it? Ann Surg Oncol. 2003;10:408\u201315.","journal-title":"Ann Surg Oncol."},{"key":"5646_CR23","doi-asserted-by":"crossref","unstructured":"Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999;230:453\u201363; discussion 63\u20135.","DOI":"10.1097\/00000658-199910000-00001"},{"key":"5646_CR24","doi-asserted-by":"crossref","unstructured":"Faries MB, Steen S, Ye X, Sim M Morton DL. Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg. 2013;217:27\u201334.","DOI":"10.1016\/j.jamcollsurg.2013.03.007"},{"key":"5646_CR25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014; 370:599\u2013609.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5646-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:37:54Z","timestamp":1498343874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5646-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["5646"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5646-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}